Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Size, Share, & Trends Analysis | United States | 2025-2032 | Includes: Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy Devices, and 7 more

List of Tables

U.S. Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Report

The U.S. cardiac rhythm management, electrophysiology and cardiac ablation market was valued at just over $15 billion in 2025. The market is expected to grow at a CAGR of 8.2 percent over the forecast period to exceed $26 billion by 2032.

This report suite provides a detailed analysis of the full arrhythmia management landscape, including implantable cardioverter defibrillators, pacemakers and leadless pacemakers, cardiac resynchronization therapy devices, cardiac leads, implantable loop recorders, external defibrillators, electrophysiology lab systems, diagnostic EP catheters and cardiac ablation catheters. Each segment includes market sizing, growth forecasts, pricing trends, replacement cycles, technology adoption patterns and competitive dynamics.

The structure and methodology follow iData Research best practices as shown in the example report , with revenue modeled from units multiplied by average selling prices and validated against procedure volumes and installed base assumptions.

Growth in this market is being driven by rising prevalence of atrial fibrillation and other cardiac arrhythmias, increasing diagnosis through advanced monitoring technologies and the continued shift toward interventional treatment. Expanding ablation volumes and rapid adoption of new technologies such as pulsed-field ablation are accelerating investment across electrophysiology labs and device platforms.

Market Overview

The U.S. cardiac rhythm management and electrophysiology market is undergoing a structural shift toward earlier diagnosis and interventional treatment of cardiac arrhythmias.

Historically, many arrhythmia patients were managed pharmacologically until symptoms progressed. Today, advances in remote monitoring, implantable loop recorders and AI-assisted ECG analysis are enabling earlier detection of clinically significant arrhythmias. This has expanded the treated patient population and increased referrals for device-based therapies and ablation procedures.

At the same time, electrophysiology labs are evolving into highly specialized procedural environments. Hospitals are investing in integrated systems that combine 3D mapping, advanced imaging and multiple ablation modalities. These investments are driven by the need to improve procedural efficiency, reduce complications and support growing case volumes.

Market growth is therefore supported by both volume expansion and technology adoption. While mature CRM segments such as pacemakers and ICDs face pricing pressure, newer technologies such as leadless pacing, extravascular defibrillators and pulsed-field ablation are supporting higher value growth.

Market Drivers

One of the primary drivers of the U.S. CRM and electrophysiology market is the improved ability to diagnose and treat cardiac arrhythmias.

Advances in digital diagnostics, including insertable cardiac monitors with smartphone connectivity, patch-based Holter monitors and AI-enhanced ECG software, are increasing detection rates. Patients are being diagnosed earlier in their disease progression, which leads to higher treatment volumes. Earlier intervention increases demand for ablation procedures and implantable devices.

Another key driver is the broadening of the patient base for implantable defibrillators. Clinical guidelines and ongoing trials continue to expand eligibility criteria for ICD and CRT therapies. Extravascular ICD systems reduce complications associated with transvenous leads and appeal to younger patients. Wearable defibrillators are also being used more frequently as temporary protection for patients at risk of sudden cardiac arrest. These trends support sustained demand across implantable and external defibrillation segments.

Technology innovation is also a major growth factor. Leadless pacemakers are expanding beyond single-chamber applications into dual-chamber configurations, increasing adoption in a wider patient population. Improvements in battery life are reducing replacement frequency and improving patient outcomes.

In electrophysiology, pulsed-field ablation is rapidly gaining traction due to its ability to reduce collateral tissue damage and shorten procedure times. Cryoablation and radiofrequency technologies continue to evolve alongside improvements in mapping accuracy and catheter design. Integration of cloud-based data systems and remote device management is also enhancing workflow efficiency and patient monitoring.

Overall, these factors are driving a shift toward minimally invasive and curative therapies, supporting strong growth across both CRM and EP segments.

Market Limiters

Despite strong growth drivers, several factors are limiting market expansion.

Accountable care organizations and large health systems are consolidating purchasing decisions. Hospitals are increasingly standardizing vendors across device categories, which reduces pricing flexibility for manufacturers. Purchasing decisions are often based on total cost of ownership rather than product differentiation, which places pressure on premium technologies.

Product recalls continue to impact the market. CRM leads, ICD generators and EP catheters have all been subject to safety communications in recent years. Even isolated events can influence physician trust and delay purchasing decisions. Increased regulatory scrutiny also adds cost and complexity for manufacturers.

Declining average selling prices remain a significant limiter, particularly in mature segments such as pacemakers, ICDs and CRT devices. As technologies mature and competition increases, pricing pressure intensifies. Hospitals are also becoming more cost sensitive due to reimbursement constraints and operational efficiency targets.

While new technologies such as pulsed-field ablation and leadless pacing can temporarily support higher pricing, the overall trend toward ASP erosion persists across the broader market.

Market Coverage and Data Scope

Quantitative coverage

Market size, market shares, market forecasts, growth rates, units sold and average selling prices.

Qualitative coverage

Market drivers and limiters, competitive analysis, company profiles and product portfolios, mergers and acquisitions, technology trends and clinical practice developments.

Time frame

Base year 2025, historical data to 2022 and forecasts through 2032.

Data sources

Primary interviews with industry stakeholders, physician data, regulatory databases, hospital procurement data and iData Research internal databases.

Methodology note

Revenue is modeled using unit volumes multiplied by average selling prices and validated against procedure data, installed base and replacement cycles.

Markets Covered and Segmentation

The U.S. cardiac rhythm management and electrophysiology market is segmented into the following categories:

Pacemaker Market

Single-chamber pacemakers and dual-chamber pacemakers.

Implantable Cardioverter Defibrillator Market

Single-chamber ICDs, dual-chamber ICDs, subcutaneous ICDs and extravascular ICDs.

Cardiac Resynchronization Therapy Market

CRT-P and CRT-D devices.

Cardiac Lead Market

Pacing leads, defibrillation leads and left ventricular leads.

Insertable Cardiac Monitor Market

Electrophysiology Lab System Market

3D mapping systems, EP recording systems, RF ablation generators and remote steering systems.

Diagnostic Electrophysiology Catheter Market

Conventional EP catheters, advanced EP catheters and intracardiac echocardiography catheters.

Cardiac Ablation Catheter Market

Radiofrequency ablation, cryoablation and pulsed-field ablation catheters.

External Defibrillator Market

Automated external defibrillators and manual external defibrillators.

Competitive Analysis

The U.S. CRM, electrophysiology and cardiac ablation market is highly concentrated, with a small number of large players controlling the majority of market share.

Boston Scientific was the overall market leader in 2025. Its leadership is driven by strong performance in electrophysiology and ablation segments, which are the fastest-growing areas of the market. The company has benefited from rapid adoption of its pulsed-field ablation platform and has strengthened its position through acquisitions in mapping and diagnostic technologies. Its portfolio breadth across both therapeutic and diagnostic categories supports continued growth.

Medtronic ranked second overall, with leading positions in pacemakers, ICDs and CRT devices. The company benefits from strong brand loyalty, a large installed base and a comprehensive service network. Its leadless pacemaker portfolio continues to drive growth in minimally invasive pacing, while its cryoballoon ablation technology maintains a strong presence in electrophysiology.

Johnson & Johnson MedTech, through Biosense Webster, is the dominant player in electrophysiology. The company leads in 3D mapping systems, diagnostic catheters and radiofrequency ablation technologies. Its CARTO mapping platform remains a standard in many EP labs. Continued investment in next-generation ablation technologies supports its competitive position.

Overall, competition is defined by portfolio breadth, clinical evidence, physician training and the ability to integrate technologies across the full arrhythmia care pathway.

Technology and Practice Trends

Technology development is reshaping the U.S. cardiac rhythm management and electrophysiology market.

Pulsed-field ablation is emerging as a transformative technology due to its safety profile and procedural efficiency. Adoption is accelerating as clinical evidence continues to support its use in atrial fibrillation treatment.

Leadless pacemakers are gaining traction due to their minimally invasive nature and reduced complication rates. The expansion into dual-chamber systems is expected to significantly increase adoption.

Remote monitoring and digital health integration are becoming standard across CRM devices. Cloud-based platforms allow physicians to monitor patients in real time, improving outcomes and reducing hospital visits.

Advances in mapping technology are improving procedural accuracy and reducing procedure times. High-definition mapping systems and integration with imaging modalities are enhancing the effectiveness of ablation procedures.

Overall, these trends are supporting a shift toward more efficient, data-driven and minimally invasive treatment approaches.

Geography

This report covers the United States.

Methodology Appendix and Acronym Glossary.

Why This Report

This report answers key strategic questions:

Where are the largest and fastest-growing opportunities within the U.S. CRM and electrophysiology market.

How shifts toward earlier diagnosis and interventional treatment are impacting device demand.

What role emerging technologies such as pulsed-field ablation and leadless pacing will play in future growth.

How pricing pressure and hospital consolidation will affect competitive dynamics.

Which segments are most likely to gain share over the forecast period.

How companies can position their portfolios to align with evolving clinical practice.

Use this report to quantify market opportunities, guide product development, support pricing strategies and inform investment decisions.

Product Code: iDATA_USCRM26_MS

TABLE OF CONTENT

List of Figures

List of Charts

executive summary

research methodology

Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

IMPACT OF GLOBAL TariffS

U.S. Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview

3.1 Introduction
3.2 Market Overview
3.3 Drivers and Limiters
- 3.3.1 Market Drivers
- 3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers and Acquisitions

Procedure Numbers

4.1 Introduction
4.2 Procedures

Pacemaker Market

5.1 Introduction
- 5.1.1 Single- and Dual-Chamber Devices
- 5.1.2 MRI-Compatible Pacemaker
- 5.1.3 Leadless Pacemaker
- 5.1.4 Initial Placement and Replacement of Pacemakers
5.2 Market Overview
5.3 Market Analysis and Forecast
- 5.3.1 Total Pacemaker Market
- 5.3.2 Total Single-Chamber Pacemaker Market
  - 5.3.2.1 Total Standard Single-Chamber Market
  - 5.3.2.2 Leadless single Chamber Pacemaker Market
- 5.3.3 Total Dual-Chamber Pacemaker Market
  - 5.3.3.1 Total Standard Dual-Chamber Market
  - 5.3.3.1.1 Leadless Dual-Chamber Pacemaker Market
5.4 Drivers and Limiters
- 5.4.1 Market Drivers
- 5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

Implantable Cardioverter defibrillator Market

6.1 Introduction
6.2 Market Overview
6.3 Market Analysis and Forecast
- 6.3.1 Total ICD Market
- 6.3.2 Total Single-Chamber ICD Market
- 6.3.3 Total Dual-Chamber ICD Market
- 6.3.4 S-ICD Market
- 6.3.5 EV-ICD Market
6.4 Drivers and Limiters
- 6.4.1 Market Drivers
- 6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

Cardiac Resynchronization therapy device Market

7.1 Introduction
- 7.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
- 7.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)
7.2 Market Overview
7.3 Market Analysis and Forecast
- 7.3.1 Total CRT Market
- 7.3.2 Total CRT-P Market
- 7.3.3 Total CRT-D Market
7.4 Drivers and Limiters
- 7.4.1 Market Drivers
- 7.4.2 Market Limiters
7.5 Competitive Market Share Analysis

Cardiac lead Market

8.1 Introduction
- 8.1.1 Replacement of Leads
8.2 Market Overview
8.3 Market Analysis and Forecast
- 8.3.1 Total Cardiac Lead Market
- 8.3.2 Pacing Lead Market
- 8.3.3 Defibrillation Lead Market
- 8.3.4 LV Lead Market
8.4 Drivers and Limiters
- 8.4.1 Market Drivers
- 8.4.2 Market Limiters
8.5 Competitive Market Share Analysis

Insertable Cardiac market

9.1 Introduction
9.2 Market Analysis and Forecast
9.3 Drivers and Limiters
- 9.3.1 Market Drivers
- 9.3.2 Market Limiters
9.4 Competitive Market Share Analysis

lab systems Market

10.1 Introduction
- 10.1.1 3D Mapping Systems
- 10.1.2 EP Recording Systems
- 10.1.3 Remote Steering Systems
- 10.1.4 RF Ablation Generator
- 10.1.5 ICE System
10.2 Market Overview
10.3 Market Analysis and Forecast
- 10.3.1 3D Mapping Market
- 10.3.2 EP Recording Market
- 10.3.3 RF Ablation Generator Market
- 10.3.4 Remote Steering System Market
10.4 Drivers and Limiters
- 10.4.1 Market Drivers
- 10.4.2 Market Limiters
10.5 Competitive Market Share Analysis

diagnostic electrophysiology catheters Market

11.1 Introduction
- 11.1.1 Diagnostic Electrophysiology Catheters
- 11.1.2 Reprocessed Catheters
- 11.1.3 Intracardiac Echocardiography
11.2 Market Overview
11.3 Market Analysis and Forecast
- 11.3.1 Total Diagnostic Electrophysiology Catheters Market
- 11.3.2 Total EP Conventional Catheter Market
- 11.3.3 Advanced Catheter Market
- 11.3.4 ICE Diagnostic Catheter Market
11.4 Drivers and Limiters
- 11.4.1 Market Drivers
- 11.4.2 Market Limiters
11.5 Competitive Market Share Analysis

Cardiac ablation Catheter Market

12.1 Introduction
12.2 Market Overview
12.3 Market Analysis and Forecast
- 12.3.1 Cardiac Ablation Catheter Market
- 12.3.2 RF Ablation Catheter Market
- 12.3.3 Cryoablation Catheter Market
- 12.3.4 Pulse Field Ablation Catheter Market
12.4 Drivers and Limiters
- 12.4.1 Market Drivers
- 12.4.2 Market Limiters
12.5 Competitive Market Share Analysis

external defibrillator market

13.1 Introduction
13.2 Market Overview
13.3 Market Analysis and Forecast
- 13.3.1 Total External Defibrillator Market
- 13.3.2 Automated External Defibrillator Market
- 13.3.3 Manual External Defibrillator Market
13.4 Drivers and Limiters
- 13.4.1 Market Drivers
- 13.4.2 Market Limiters
13.5 Competitive Market Share Analysis

Abbreviations

Product Code: iDATA_USCRM26_MS

LIST OF CHARTS

Chart 1-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2022 - 2032
Chart 1-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview, U.S., 2025 & 2032
Chart 3-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2022 - 2032
Chart 3-2: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2025
Chart 4-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2022 - 2032
Chart 5-1: Pacemaker Market by Segment, U.S., 2022 - 2032
Chart 5-2: Leading Competitors, Pacemaker Market, U.S., 2025
Chart 6-1: ICD Market by Segment, U.S., 2022 - 2032
Chart 6-2: Leading Competitors, ICD Market, U.S., 2025
Chart 7-1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2022 - 2032
Chart 7-2: Leading Competitors, CRT Market, U.S., 2025
Chart 8-1: Cardiac Lead Market by Segment, U.S., 2022 - 2032
Chart 8-2: Leading Competitors, Cardiac Lead Market, U.S., 2025
Chart 9-1: Insertable Cardiac Monitor Market, U.S., 2022 - 2032
Chart 9-2: Leading Competitors, Insertable Cardiac Monitor Market, US, 2025
Chart 10-1: Lab Systems Market by Segment, U.S., 2022 - 2032
Chart 10-2: Leading Competitors, Lab Systems Market, U.S., 2025
Chart 11-1: Diagnostic Electrophysiology Catheters Market by Segment, U.S., 2022 - 2032
Chart 11-2: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2025
Chart 12-1: Cardiac Ablation Catheter Market by Segment, U.S., 2022 - 2032
Chart 12-2: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2025
Chart 13-1: External Defibrillator Market by Segment, U.S., 2022 - 2032
Chart 13-2: Leading Competitors, External Defibrillator Market, U.S., 2025

LIST OF FIGURES

Figure 1-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, U.S., 2025 (1 of 2)
Figure 1-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, U.S., 2025 (2 of 2)
Figure 1-3: Companies Researched in this Report
Figure 1-4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S. (1 of 2)
Figure 1-5: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S. (2 of 2)
Figure 1-6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2022 - 2025
Figure 1-7: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered
Figure 1-8: Procedure Codes Investigated
Figure 1-9: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered, (1 of 2)
Figure 1-10: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered (2 of 2)
Figure 1-11: Key analysis Updates
Figure 1-12: Key Report Updates
Figure 1-13: Version History
Figure 3-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2022 - 2032 (US$M) (1 of 2)
Figure 3-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2022 - 2032 (US$M) (2 of 2)
Figure 3-3: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2025 (1 of 2)
Figure 3-4: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2025 (2 of 2)
Figure 4-1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2022 - 2032 (1 of 2)
Figure 4-2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2022 - 2032 (2 of 2)
Figure 5-1: Pacemaker Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 5-2: Total Pacemaker Market, U.S., 2022 - 2032
Figure 5-3: Standard Single-Chamber Pacemaker Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 5-4: Total Single-Chamber Pacemaker Market, U.S., 2022 - 2032
Figure 5-5: Total Standard Single-Chamber Pacemaker Market, U.S., 2022 - 2032
Figure 5-6: Initial Placement Standard Single-Chamber Pacemaker Market, U.S., 2022 - 2032
Figure 5-7: Replacement Standard Single-Chamber Pacemaker Market, U.S., 2022 - 2032
Figure 5-8: Leadless Standard single-chamber Pacemaker Market, U.S., 2022 - 2032
Figure 5-9: Dual-Chamber Pacemaker Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 5-10: Total Dual-Chamber Pacemaker Market, U.S., 2022 - 2032
Figure 5-11: Total Standard Dual-Chamber Pacemaker Market, U.S., 2022 - 2032
Figure 5-12: Initial Placement Dual-Chamber Pacemaker Market, U.S., 2022 - 2032
Figure 5-13: Replacement Standard Dual-Chamber Pacemaker Market, U.S., 2022 - 2032
Figure 5-14: Leadless Dual-Chamber Pacemaker Market, U.S., 2022 - 2032
Figure 5-15: Leading Competitors by Brand, Pacemaker Market, U.S., 2025
Figure 5-16: Leading Competitors, Pacemaker Market, U.S., 2025
Figure 5-17: Leading Competitors, Single Chamber Pacemaker Market, U.S., 2025
Figure 5-18: Leading Competitors, Dual Chamber Pacemaker Market, U.S., 2025
Figure 5-19: Leading Competitors, Pacemaker Market, U.S., 2024
Figure 5-20: Leading Competitors, Single Chamber Pacemaker Market, U.S., 2024
Figure 5-21: Leading Competitors, Dual Chamber Pacemaker Market, U.S., 2024
Figure 5-22: Leading Competitors, Pacemaker Market, U.S., 2023
Figure 5-23: Leading Competitors, Single Chamber Pacemaker Market, U.S., 2023
Figure 5-24: Leading Competitors, Dual Chamber Pacemaker Market, U.S., 2023
Figure 6-1: ICD Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 6-2: Total ICD Market, U.S., 2022 - 2032
Figure 6-3: Single-Chamber ICD Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 6-4: Total Single-Chamber ICD Market, U.S., 2022 - 2032
Figure 6-5: Initial Placement Single-Chamber ICD Market, U.S., 2022 - 2032
Figure 6-6: Replacement Single-Chamber ICD Market, U.S., 2022 - 2032
Figure 6-7: Dual-Chamber ICD Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 6-8: Total Dual-Chamber ICD Market, U.S., 2022 - 2032
Figure 6-9: Initial Placement Dual-Chamber ICD Market, U.S., 2022 - 2032
Figure 6-10: Replacement Dual-Chamber ICD Market, U.S., 2022 - 2032
Figure 6-11: S-ICD Market, U.S., 2022 - 2032
Figure 6-12: EV-ICD Market, U.S., 2022 - 2032
Figure 6-13: Leading Competitors by Brand, ICD Market, U.S., 2025
Figure 6-14: Leading Competitors, ICD Market, U.S., 2025
Figure 6-15: Leading Competitors, ICD Market, U.S., 2024
Figure 6-16: Leading Competitors, ICD Market, U.S., 2023
Figure 7-1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 7-2: Total CRT Market, U.S., 2022 - 2032
Figure 7-3: CRT-P Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 7-4: Total CRT-P Market, U.S., 2022 - 2032
Figure 7-5: Initial Placement CRT-P Market, U.S., 2022 - 2032
Figure 7-6: Replacement CRT-P Market, U.S., 2022 - 2032
Figure 7-7: CRT-D Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 7-8: Total CRT-D Market, U.S., 2022 - 2032
Figure 7-9: Initial Placement CRT-D Market, U.S., 2022 - 2032
Figure 7-10: Replacement CRT-D Market, U.S., 2022 - 2032
Figure 7-11: Leading Competitors by Brand, CRT Market, U.S., 2025
Figure 7-12: Leading Competitors, CRT Market, U.S., 2025
Figure 7-13: Leading Competitors, CRT Market, U.S., 2024
Figure 7-14: Leading Competitors, CRT Market, U.S., 2023
Figure 8-1: Cardiac Lead Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 8-2: Total Cardiac Lead Market, U.S., 2022 - 2032
Figure 8-3: Pacing Lead Market, U.S., 2022 - 2032
Figure 8-4: CSP Pacing Lead Market, U.S., 2022 - 2032
Figure 8-5: Non-CSP Pacing Lead Market, U.S., 2022 - 2032
Figure 8-6: Defibrillation Lead Market, U.S., 2022 - 2032
Figure 8-7: LV Lead Market, U.S., 2022 - 2032
Figure 8-8: Leading Competitors, Cardiac Lead Market, U.S., 2025
Figure 9-1: Implantable Loop Recorder Market, U.S, 2022 - 2032
Figure 9-2: Leading Competitors by Brand, Insertable Cardiac Monitor Market, U.S., 2025
Figure 9-3: Leading Competitors, Insertable Cardiac Monitor Market, U.S., 2025
Figure 9-4: Leading Competitors, Insertable Cardiac Monitor Market, U.S., 2024
Figure 9-5: Leading Competitors, Insertable Cardiac Monitor Market, U.S., 2023
Figure 10-1: Lab Systems Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 10-2: 3D Mapping Market, U.S., 2022 - 2032
Figure 10-3: EP Recording Market, U.S., 2022 - 2032
Figure 10-4: RF Ablation Generator Market, U.S., 2022 - 2032
Figure 10-5: Remote Steering System Market, U.S., 2022 - 2032
Figure 10-6: Leading Competitors, Lab Systems Market, U.S., 2025
Figure 11-1: Diagnostic Electrophysiology Catheters Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 11-2: Total Diagnostic Electrophysiology Catheters Market, U.S., 2022 - 2032
Figure 11-3: EP Conventional Catheter Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 11-4: Total EP Conventional Catheter Market, U.S., 2022 - 2032
Figure 11-5: Fixed EP Catheter Market, U.S., 2022 - 2032
Figure 11-6: Steerable EP Catheter Market, U.S., 2022 - 2032
Figure 11-7: EP Advanced Catheter Market, U.S., 2022 - 2032
Figure 11-8: ICE Diagnostic Catheter Market, U.S., 2022 - 2032
Figure 11-9: Leading Competitors by Brand, Diagnostic Electrophysiology Catheters Market, U.S., 2025 (1 of 2)
Figure 11-10: Leading Competitors by Brand, Diagnostic Electrophysiology Catheters Market, U.S., 2025 (2 of 2)
Figure 11-11: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2025
Figure 11-12: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2024
Figure 11-13: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2023
Figure 12-1: Cardiac Ablation Catheter Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 12-2: Cardiac Ablation Catheter Market, U.S., 2022 - 2032
Figure 12-3: RF Ablation Catheter Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 12-4: Total RF Ablation Catheter Market, U.S., 2022 - 2032
Figure 12-5: Irrigated RF Ablation Catheter Market, U.S., 2022 - 2032
Figure 12-6: Non-Irrigated RF Ablation Catheter Market, U.S., 2022 - 2032
Figure 12-7: Cryoablation Catheter Market, U.S., 2022 - 2032
Figure 12-8: Pulse Field Ablation Catheter Market, U.S., 2022 - 2032
Figure 12-9: Leading Competitors by Brand, Cardiac Ablation Catheter Market, U.S., 2025
Figure 12-10: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2025
Figure 12-11: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2024
Figure 12-12: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2023
Figure 13-1: External Defibrillator Market by Segment, U.S., 2022 - 2032 (US$M)
Figure 13-2: Total External Defibrillator Market, U.S., 2022 - 2032
Figure 13-3: Automated External Defibrillator Market, U.S., 2022 - 2032
Figure 13-4: Manual External Defibrillator Market, U.S., 2022 - 2032
Figure 13-5: Leading Competitors, External Defibrillator Market, U.S., 2025